Development and validation of a dried blood spot test for thiamine deficiency among infants by HPLC–fluorimetry

Elizabeth Mary Mathew, Pradnya Sakore, Leslie Lewis, Kalaivani Manokaran, Pragna Rao, Sudheer Moorkoth

Research output: Contribution to journalArticle

Abstract

Thiamine deficiency, if detected early in infancy, can be treated with thiamine supplementation and can prevent seizures, other disabilities and death. The dried blood spot (DBS) sampling technique is an attractive sample collection technique for infants. The present study reports the development and validation of a highly sensitive and precise method for quantification of thiamine diphosphate from DBS. The method utilizes full-spot analysis of a volumetrically deposited 40 μl DBS. The analyte was extracted from the DBS using 50% methanol and then derivatized using potassium ferricyanide to thiochrome. Separation was achieved with the help of an Inertsil ODS C18 column (5.0 μm, 250 × 4.6 mm) using 150 mm phosphate buffer pH 7–acetonitrile (90:10, % v/v) as the mobile phase. The use of a fluorimetric detector gave a good response to the thiochrome derivative offering good sensitivity for the method. The excitation and emission wavelengths were 367 and 435 nm, respectively. The limit of detection and lower limit of quantification were 5 and 10 ng/ml, respectively. Linearity was demonstrated from 10 to 1000 ng/ml, and precision (CV) was <12.08%, at all tested quality control levels. The method accuracy was 89.34–118.89% with recoveries >80%. Bland–Altman analysis of DBS sampling vs. whole blood demonstrated a mean bias of only 1.16 ng/ml, with a majority of the 60 investigated patient samples lying within 7.2% of the corresponding concentration measured in blood, thereby meeting the clinical desirable biological specification criterion and showing that the two methods are comparable.

Original languageEnglish
Article numbere4668
JournalBiomedical Chromatography
Volume33
Issue number11
DOIs
Publication statusPublished - 01-11-2019

Fingerprint

Thiamine Deficiency
Thiamine
Hematologic Tests
Blood
Dried Blood Spot Testing
Thiamine Pyrophosphate
Sampling
Methanol
Limit of Detection
Buffers
Seizures
Phosphates
Derivatives
Detectors
Specifications
Wavelength

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

@article{3d7263c08b7c42a09e2137953a6d725a,
title = "Development and validation of a dried blood spot test for thiamine deficiency among infants by HPLC–fluorimetry",
abstract = "Thiamine deficiency, if detected early in infancy, can be treated with thiamine supplementation and can prevent seizures, other disabilities and death. The dried blood spot (DBS) sampling technique is an attractive sample collection technique for infants. The present study reports the development and validation of a highly sensitive and precise method for quantification of thiamine diphosphate from DBS. The method utilizes full-spot analysis of a volumetrically deposited 40 μl DBS. The analyte was extracted from the DBS using 50{\%} methanol and then derivatized using potassium ferricyanide to thiochrome. Separation was achieved with the help of an Inertsil ODS C18 column (5.0 μm, 250 × 4.6 mm) using 150 mm phosphate buffer pH 7–acetonitrile (90:10, {\%} v/v) as the mobile phase. The use of a fluorimetric detector gave a good response to the thiochrome derivative offering good sensitivity for the method. The excitation and emission wavelengths were 367 and 435 nm, respectively. The limit of detection and lower limit of quantification were 5 and 10 ng/ml, respectively. Linearity was demonstrated from 10 to 1000 ng/ml, and precision (CV) was <12.08{\%}, at all tested quality control levels. The method accuracy was 89.34–118.89{\%} with recoveries >80{\%}. Bland–Altman analysis of DBS sampling vs. whole blood demonstrated a mean bias of only 1.16 ng/ml, with a majority of the 60 investigated patient samples lying within 7.2{\%} of the corresponding concentration measured in blood, thereby meeting the clinical desirable biological specification criterion and showing that the two methods are comparable.",
author = "Mathew, {Elizabeth Mary} and Pradnya Sakore and Leslie Lewis and Kalaivani Manokaran and Pragna Rao and Sudheer Moorkoth",
year = "2019",
month = "11",
day = "1",
doi = "10.1002/bmc.4668",
language = "English",
volume = "33",
journal = "Biomedical Chromatography",
issn = "0269-3879",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

Development and validation of a dried blood spot test for thiamine deficiency among infants by HPLC–fluorimetry. / Mathew, Elizabeth Mary; Sakore, Pradnya; Lewis, Leslie; Manokaran, Kalaivani; Rao, Pragna; Moorkoth, Sudheer.

In: Biomedical Chromatography, Vol. 33, No. 11, e4668, 01.11.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of a dried blood spot test for thiamine deficiency among infants by HPLC–fluorimetry

AU - Mathew, Elizabeth Mary

AU - Sakore, Pradnya

AU - Lewis, Leslie

AU - Manokaran, Kalaivani

AU - Rao, Pragna

AU - Moorkoth, Sudheer

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Thiamine deficiency, if detected early in infancy, can be treated with thiamine supplementation and can prevent seizures, other disabilities and death. The dried blood spot (DBS) sampling technique is an attractive sample collection technique for infants. The present study reports the development and validation of a highly sensitive and precise method for quantification of thiamine diphosphate from DBS. The method utilizes full-spot analysis of a volumetrically deposited 40 μl DBS. The analyte was extracted from the DBS using 50% methanol and then derivatized using potassium ferricyanide to thiochrome. Separation was achieved with the help of an Inertsil ODS C18 column (5.0 μm, 250 × 4.6 mm) using 150 mm phosphate buffer pH 7–acetonitrile (90:10, % v/v) as the mobile phase. The use of a fluorimetric detector gave a good response to the thiochrome derivative offering good sensitivity for the method. The excitation and emission wavelengths were 367 and 435 nm, respectively. The limit of detection and lower limit of quantification were 5 and 10 ng/ml, respectively. Linearity was demonstrated from 10 to 1000 ng/ml, and precision (CV) was <12.08%, at all tested quality control levels. The method accuracy was 89.34–118.89% with recoveries >80%. Bland–Altman analysis of DBS sampling vs. whole blood demonstrated a mean bias of only 1.16 ng/ml, with a majority of the 60 investigated patient samples lying within 7.2% of the corresponding concentration measured in blood, thereby meeting the clinical desirable biological specification criterion and showing that the two methods are comparable.

AB - Thiamine deficiency, if detected early in infancy, can be treated with thiamine supplementation and can prevent seizures, other disabilities and death. The dried blood spot (DBS) sampling technique is an attractive sample collection technique for infants. The present study reports the development and validation of a highly sensitive and precise method for quantification of thiamine diphosphate from DBS. The method utilizes full-spot analysis of a volumetrically deposited 40 μl DBS. The analyte was extracted from the DBS using 50% methanol and then derivatized using potassium ferricyanide to thiochrome. Separation was achieved with the help of an Inertsil ODS C18 column (5.0 μm, 250 × 4.6 mm) using 150 mm phosphate buffer pH 7–acetonitrile (90:10, % v/v) as the mobile phase. The use of a fluorimetric detector gave a good response to the thiochrome derivative offering good sensitivity for the method. The excitation and emission wavelengths were 367 and 435 nm, respectively. The limit of detection and lower limit of quantification were 5 and 10 ng/ml, respectively. Linearity was demonstrated from 10 to 1000 ng/ml, and precision (CV) was <12.08%, at all tested quality control levels. The method accuracy was 89.34–118.89% with recoveries >80%. Bland–Altman analysis of DBS sampling vs. whole blood demonstrated a mean bias of only 1.16 ng/ml, with a majority of the 60 investigated patient samples lying within 7.2% of the corresponding concentration measured in blood, thereby meeting the clinical desirable biological specification criterion and showing that the two methods are comparable.

UR - http://www.scopus.com/inward/record.url?scp=85071743717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071743717&partnerID=8YFLogxK

U2 - 10.1002/bmc.4668

DO - 10.1002/bmc.4668

M3 - Article

C2 - 31353499

AN - SCOPUS:85071743717

VL - 33

JO - Biomedical Chromatography

JF - Biomedical Chromatography

SN - 0269-3879

IS - 11

M1 - e4668

ER -